Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptide-based cancer vaccines

C J Melief1, R Offringa, R E Toes

  • 1Department of Immunohaematology, University Hospital of Leiden, The Netherlands. ihbsecr@euronet.nl

Current Opinion in Immunology
|October 1, 1996
PubMed
Summary

Molecularly defined vaccines targeting tumor epitopes show promise for cancer immunity. Further research comparing delivery methods is crucial for developing effective and safe clinical cancer vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of tumor-reactive T cell receptors from scRNA-seq data for personalized T cell therapy.

Nature biotechnology·2024
Same author

Diminished medial prefrontal cortex activation during the recollection of stressful events is an acquired characteristic of PTSD.

Psychological medicine·2017
Same author

Possibilities for preventive treatment in rheumatoid arthritis? Lessons from experimental animal models of arthritis: a systematic literature review and meta-analysis.

Annals of the rheumatic diseases·2016
Same author

T-cell regulation of human B-cell activation. A reappraisal of the role of interleukin 2.

Immunology today·2014
Same author

Studying associations between variants in TRAF1-C5 and TNFAIP3-OLIG3 and the progression of joint destruction in rheumatoid arthritis in multiple cohorts.

Annals of the rheumatic diseases·2012
Same author

Anti-H-2 antibodies induced by syngeneic immunization.

Immunogenetics·2012

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Molecularly defined vaccines use specific tumor epitopes to induce T cell immunity.
  • These vaccines have shown protective antitumor effects in mouse models.
  • Early human trials indicate encouraging results for T cell-based cancer vaccines.

Purpose of the Study:

  • To compare different delivery methods for tumor-associated T cell epitopes.
  • To evaluate multi-epitope constructs for enhanced vaccine efficacy.
  • To inform the design of next-generation cancer vaccines for clinical use.

Main Methods:

  • Utilizing molecularly defined vaccines with limited tumor-specific T cell epitopes.
  • Administering multi-epitope constructs via various delivery systems.
  • Assessing the induction of protective antitumor T cell immunity.

Main Results:

  • Demonstrated protective antitumor T cell immunity in multiple mouse tumor models.
  • Observed encouraging initial outcomes in human subjects.
  • Established a basis for comparing delivery strategies.

Conclusions:

  • Molecularly defined vaccines represent a promising strategy for cancer immunotherapy.
  • Comparative analysis of delivery methods is essential for clinical translation.
  • Further development is needed to optimize safety and efficacy in humans.

Related Experiment Videos